Literature DB >> 23816675

Emergent cardiopulmonary bypass during pectus excavatum repair.

Ryan Craner1, Ricardo Weis, Harish Ramakrishna.   

Abstract

Pectus excavatum is a chest wall deformity that produces significant cardiopulmonary disability and is typically seen in younger patients. Minimally invasive repair of pectus excavatum or Nuss procedure has become a widely accepted technique for adult and pediatric patients. Although it is carried out through a thoracoscopic approach, the procedure is associated with a number of potential intraoperative and post-operative complications. We present a case of cardiac perforation requiring emergent cardiopulmonary bypass in a 29-year-old male with Marfan syndrome and previous mitral valve repair undergoing a Nuss procedure for pectus excavatum. This case illustrates the importance of vigilance and preparation by the surgeons, anesthesia providers as well as the institution to be prepared with resources to handle the possible complications. This includes available cardiac surgical backup, perfusionist support and adequate blood product availability.

Entities:  

Mesh:

Year:  2013        PMID: 23816675     DOI: 10.4103/0971-9784.114249

Source DB:  PubMed          Journal:  Ann Card Anaesth        ISSN: 0971-9784


  3 in total

1.  Management of severe asymmetric pectus excavatum complicating aortic repair in a patient with Marfan's syndrome.

Authors:  Jonathan C Yeung; Danny Marcuzzi; Mark D Peterson; Michael A Ko
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-02-13

Review 2.  Anesthesia for minimally invasive chest wall reconstructive surgeries: Our experience and review of literature.

Authors:  Shagun Bhatia Shah; Uma Hariharan; Ajay Kumar Bhargava; Laleng M Darlong
Journal:  Saudi J Anaesth       Date:  2017 Jul-Sep

3.  Aortic root replacement and valvuloplasty in a woman with severe pectus excavatum.

Authors:  Panagiotis Kalogris; Kosmas Iliadis; Gregory Amanatidis; Alexandros Demis; Anna Smyrli; Konstantinos Petsios
Journal:  J Cardiovasc Thorac Res       Date:  2018-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.